These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3810908)

  • 21. Neurologic complications in diabetics after metrizamide lumbar myelography.
    Steiner E; Simon JH; Ekholm SE; Erickson J; Kido DK; Okawara S
    AJR Am J Roentgenol; 1986 May; 146(5):1057-60. PubMed ID: 3485900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of lumbar myelography with amipaque and dimer-X.
    Irstam L; Selldén U
    Acta Radiol Diagn (Stockh); 1976 Mar; 17(2):145-59. PubMed ID: 1274652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lumbar myelography with metrizamide-a new non-ionic contrast medium.
    Grainger RG
    Br J Radiol; 1976 Dec; 49(588):996-1003. PubMed ID: 793673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using metrizamide for lumbar myelography: adverse reactions and nursing implications.
    Byers VL; Gendell H
    J Neurosurg Nurs; 1982 Dec; 14(6):315-7. PubMed ID: 6924690
    [No Abstract]   [Full Text] [Related]  

  • 25. Cervical myelography with metrizamide using lumbar injection.
    Sortland O
    Acta Radiol Suppl; 1977; 355():141-53. PubMed ID: 299663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized blind trial of iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculography.
    McAllister VL; Hall K
    Neuroradiology; 1983; 24(4):217-8. PubMed ID: 6338415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.
    Yu YL; du Boulay GH; Paul E
    Neuroradiology; 1986; 28(4):339-43. PubMed ID: 3762912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.
    Gonsette RE
    Acta Radiol Suppl; 1973; 335():346-58. PubMed ID: 4549779
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric myelography with metrizamide.
    Fitz CR; Harwood-Nash DC; Barry JF; Byrd SE
    Acta Radiol Suppl; 1977; 355():182-92. PubMed ID: 299668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelography with metrizamide.
    Peeters FL
    Radiol Clin (Basel); 1977; 46(3):203-13. PubMed ID: 404661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of levomepromazine on EEG and on clinical side effects after lumbar myelography with metrizamide.
    Standnes B; Oftedal SI; Weber H
    Acta Radiol Diagn (Stockh); 1982; 23(2):111-4. PubMed ID: 7090846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and antiemetic effects of metoclopramide in metrizamide myelography.
    Goldsmith TL; Norton JA; Young AB; Tibbs PA; Dempsey RJ; Rapp RP
    Clin Pharm; 1987 Oct; 6(10):807-10. PubMed ID: 3505844
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of adverse effects following metrizamide myelography in nonambulatory and ambulatory patients.
    Sykes RH; Wasenaar W; Clark P
    Radiology; 1981 Mar; 138(3):625-7. PubMed ID: 7465839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positioning of patients after metrizamide lumbar myelography.
    Robertson WD; Lapointe JS; Nugent RA; Robinson RG; Daly LF
    AJR Am J Roentgenol; 1980 May; 134(5):947-8. PubMed ID: 6768270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side effects following metrizamide myelography and lumbar laminectomy.
    Jones AG; Meinecke E; Becker J; Spoo K
    J Neurosci Nurs; 1987 Apr; 19(2):90-4. PubMed ID: 2952744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical trial of Amipaque in lumbar myelography.
    Hansen EB; Praestholm J; Fahrenkrug A; Bjerrum J
    Br J Radiol; 1976 Jan; 49(577):34-8. PubMed ID: 776316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adverse reactions in metrizamide-meatocisternography (author's transl)].
    Schmidt CL; Bockenheimer S
    Laryngol Rhinol Otol (Stuttg); 1979 Apr; 58(4):366-8. PubMed ID: 312415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient low-dose computed tomography metrizamide myelography and evaluation of lumbar disk disease.
    Dublin AB; Reid MH
    J Comput Tomogr; 1984 Apr; 8(2):113-7. PubMed ID: 6713922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible neurologic complications of metrizamide myelography.
    Meador K; Hamilton WJ; El Gammal TA; Demetropoulos KC; Nichols FT
    Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of the gastrointestinal side effects of metrizamide myelography with oral dexamethasone.
    Smoker WR; Lehmann TR; Hingtgen WL; Spratt KF; Gentry LR; Weinstein JN
    AJNR Am J Neuroradiol; 1988; 9(1):179-85. PubMed ID: 2963509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.